Living Cell Technologies to hold board strategy meeting in December

Living Cell Technologies to hold board strategy meeting in December
Rebecca Howard
By Rebecca Howard Nov. 15 (BusinessDesk) - Living Cell Technologies will continue to evaluate data from its recent clinical trial before holding a board strategy meeting in December, chief executive Ken Taylor told shareholders at the annual general meeting. Earlier this week, the ASX-listed Kiwi biotech firm saw its market capitalisation tumbled to A$20 million from about A$160 million when it said its latest trial didn't show a "statistically significant difference" between people who received its treatment for Parkinson's disease and a...